Detalhe da pesquisa
1.
Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids.
Int J Mol Sci
; 23(6)2022 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35328625
2.
Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer.
J Transl Med
; 18(1): 214, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466781
3.
PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche.
J Transl Med
; 12: 275, 2014 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25278011
4.
Tumor infiltrating B-cells are increased in prostate cancer tissue.
J Transl Med
; 12: 30, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24475900
5.
Prostate Cancer Progression Relies on the Mitotic Kinase Citron Kinase.
Cancer Res
; 83(24): 4142-4160, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801613
6.
A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand.
Sci Adv
; 7(33)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380625
7.
Establishment and Analysis of Three-Dimensional (3D) Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts.
J Vis Exp
; (156)2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32065165
8.
Hypoxia-induced PIM kinase and laminin-activated integrin α6 mediate resistance to PI3K inhibitors in bone-metastatic CRPC.
Am J Clin Exp Urol
; 7(4): 297-312, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511835
9.
Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer.
Asian J Urol
; 3(4): 229-239, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29264191